Severe Pulmonary Adverse Effects in Lymphoma Patients Treated with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) Regimen Plus Rituximab

BACKGROUND/AIMS: The aim of our study was to determine the incidence and clinical features of severe pulmonary complications in patients receiving cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or rituximab plus CHOP (R-CHOP) as the initial treatment for lymphoma. METHODS: A retro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lim, Kyu-Hyoung, Yoon, Ho-Il, Kang, Young Ae, Lee, Keun-Wook, Kim, Jee Hyun, Bang, Soo-Mee, Lee, Jae Ho, Lee, Choon-Taek, Lee, Jong Seok
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Association of Internal Medicine 2010
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2829422/
https://ncbi.nlm.nih.gov/pubmed/20195409
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2010.25.1.86
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados